APA (7th ed.) Citation

Ansari, M., Sauty, G., Labuda, M., Gagné, V., Rousseau, J., Moghrabi, A., . . . Krajinovic, M. (2012). Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia. Pharmacogenomics Journal, 12(5), 386. https://doi.org/10.1038/tpj.2011.17

Chicago Style (17th ed.) Citation

Ansari, M., G. Sauty, M. Labuda, V. Gagné, J. Rousseau, A. Moghrabi, C. Laverdière, D. Sinnett, and M. Krajinovic. "Polymorphism in Multidrug Resistance-associated Protein Gene 3 Is Associated with Outcomes in Childhood Acute Lymphoblastic Leukemia." Pharmacogenomics Journal 12, no. 5 (2012): 386. https://doi.org/10.1038/tpj.2011.17.

MLA (9th ed.) Citation

Ansari, M., et al. "Polymorphism in Multidrug Resistance-associated Protein Gene 3 Is Associated with Outcomes in Childhood Acute Lymphoblastic Leukemia." Pharmacogenomics Journal, vol. 12, no. 5, 2012, p. 386, https://doi.org/10.1038/tpj.2011.17.